This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maródi, L.
Right arrow Articles by Nemes, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maródi, L.
Right arrow Articles by Nemes, E.

 Previous Article  |  Next Article 

Infection and Immunity, April 2000, p. 2167-2170, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Survival of Group B Streptococcus Type III in Mononuclear Phagocytes: Differential Regulation of Bacterial Killing in Cord Macrophages by Human Recombinant Gamma Interferon and Granulocyte-Macrophage Colony-Stimulating Factor

László Maródi,* Rita Káposzta, and Éva Nemes

Department of Infectology and Pediatric Immunology, Medical and Health Science Center, University of Debrecen, Debrecen, Hungary

Received 4 October 1999/Returned for modification 30 November 1999/Accepted 14 January 2000

Phagocytic and killing capacities of resident and cytokine-activated human macrophages against group B Streptococcus (GBS) type III were studied. Evidence is presented that monocyte-derived macrophages from cord and adults ingest serum-opsonized GBS but that killing of bacteria was negligible in resident cells. Treatment of adult macrophages with recombinant human gamma interferon (rhIFN-gamma ; 100 U/ml) or recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF; 200 U/ml) resulted in significant increases of killing of GBS (P < 0.01 for each). The killing capacity of cord macrophages treated with rhGM-CSF was also enhanced compared to that of untreated cells (P < 0.01). However, treatment with rhIFN-gamma resulted in only a moderate increase in the capacity of cord macrophages to kill GBS (P > 0.1). These results mirrored the effect of rhIFN-gamma on candidacidal capacities of cord and adult macrophages, reported earlier from our laboratory. These data indicate differential modulation of neonatal macrophages by rhGM-CSF and rhIFN-gamma . We suggest that administration of rhGM-CSF to neonates with invasive GBS disease may enhance host resistance to these bacteria.


* Corresponding author. Mailing address: Department of Infectology and Pediatric Immunology, Medical and Health Science Center, University of Debrecen, POB:32, H-4012 Debrecen, Hungary. Phone: (36) (52) 416 841. Fax: (36) (52) 430-323. E-mail: LMarodi{at}jaguar.dote.hu.


Infection and Immunity, April 2000, p. 2167-2170, Vol. 68, No. 4
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Szabo, J., Dobay, O., Erdos, M., Borbely, A., Rozgonyi, F., Marodi, L. (2007). Recurrent infection with genetically identical pneumococcal isolates in a patient with interleukin-1 receptor-associated kinase-4 deficiency. J Med Microbiol 56: 863-865 [Abstract] [Full Text]  
  • Marodi, L. (2006). Neonatal Innate Immunity to Infectious Agents. Infect. Immun. 74: 1999-2006 [Full Text]  
  • Henneke, P., Morath, S., Uematsu, S., Weichert, S., Pfitzenmaier, M., Takeuchi, O., Muller, A., Poyart, C., Akira, S., Berner, R., Teti, G., Geyer, A., Hartung, T., Trieu-Cuot, P., Kasper, D. L., Golenbock, D. T. (2005). Role of Lipoteichoic Acid in the Phagocyte Response to Group B Streptococcus. J. Immunol. 174: 6449-6455 [Abstract] [Full Text]  
  • Cheng, Q., Carlson, B., Pillai, S., Eby, R., Edwards, L., Olmsted, S. B., Cleary, P. (2001). Antibody against Surface-Bound C5a Peptidase Is Opsonic and Initiates Macrophage Killing of Group B Streptococci. Infect. Immun. 69: 2302-2308 [Abstract] [Full Text]